PYXS’ micvotabart pelidotin faces head & neck cancer competition, side effects and funding risk. See fall 2026 catalyst, ...

Detailed price information for Pyxis Oncology Inc (PYXS-Q) from The Globe and Mail including charting and trades.

Detailed price information for Pyxis Oncology Inc (PYXS-Q) from The Globe and Mail including charting and trades.

Maroussi, Greece – June 24, 2026 – Pyxis Tankers Inc. (Nasdaq Capital Market: PXS) (the "Company" or "Pyxis Tankers"), an international shipping company, today provided an operational update regarding ...

Expected to extend cash runway into the second quarter of 2027, supporting additional follow-up for 2L+ R/M HNSCC patients treated with MICVO at or below a dose cap Company now expects updated Phase 1 ...

From cutting energy costs to unlocking new markets, see how companies in Singapore are proving that going green is a long-term driver for growth and resilience. Read more at straitstimes.com. Read ...

Pyxis Oncology, Inc. engages in the business of developing a multi-modality portfolio of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. The ...

Muhsin discussed how BD is rolling out a new medication dispenser and a software platform that pulls together data from the company’s various devices.

Omen AI raised a $31 million Series A to monitor chip coolant and stop bacterial outbreaks in data centers.

Add Yahoo as a preferred source to see more of our stories on Google. Jun. 26—This spring, Greater Regional Health created their Mobile Integrated Health Services Department, the first standalone MIH ...